EC clears new class of anaemia therapy by Selina McKee | Jun 29, 2020 | News | 0 BMS’ Reblozyl is the first and only erythroid maturation agent approved in the EU Read More
Celgene, Acceleron to file MDS therapy in the EU, US by Selina McKee | Jul 2, 2018 | News | 0 Celgene and Acceleron Pharma are preparing to file their experimental myelodysplastic syndromes (MDS) therapy on both sides of the Atlantic on the back of promising data from a late-stage study. Read More